BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35952460)

  • 21. Effectiveness of Acupuncture Treatment on Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized, Assessor-Blinded, Controlled Trial.
    Iravani S; Kazemi Motlagh AH; Emami Razavi SZ; Shahi F; Wang J; Hou L; Sun W; Afshari Fard MR; Aghili M; Karimi M; Rezaeizadeh H; Zhao B
    Pain Res Manag; 2020; 2020():2504674. PubMed ID: 32676134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography.
    Schroeder S; Meyer-Hamme G; Epplée S
    Acupunct Med; 2012 Mar; 30(1):4-7. PubMed ID: 22146780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.
    Knoerl R; Mazzola E; Hong F; Salehi E; McCleary N; Ligibel J; Reyes K; Berry DL
    BMC Cancer; 2021 Mar; 21(1):236. PubMed ID: 33676431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).
    Misawa S; Denda T; Kodama S; Suzuki T; Naito Y; Kogawa T; Takada M; Suichi T; Shiosakai K; Kuwabara S;
    BMC Cancer; 2023 Nov; 23(1):1098. PubMed ID: 37951905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer.
    Ben-Horin I; Kahan P; Ryvo L; Inbar M; Lev-Ari S; Geva R
    Integr Cancer Ther; 2017 Sep; 16(3):258-262. PubMed ID: 28150504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness and safety of acupuncture/electroacupuncture for chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Pei LX; Yi Y; Guo J; Chen L; Zhou JY; Wu XL; Sun JH; Chen H
    Acupunct Med; 2023 Apr; 41(2):73-85. PubMed ID: 35695033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy.
    Yeo F; Ng CC; Loh KWJ; Molassiotis A; Cheng HL; Au JSK; Leung KT; Li YC; Wong KH; Suen L; Chan CW; Yorke J; Farrell C; Bandla A; Ang E; Lopez V; Sundar R; Chan A
    Support Care Cancer; 2019 Dec; 27(12):4753-4762. PubMed ID: 30972646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population.
    Mols F; van de Poll-Franse LV; Vreugdenhil G; Beijers AJ; Kieffer JM; Aaronson NK; Husson O
    Eur J Cancer; 2016 Dec; 69():28-38. PubMed ID: 27814471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review and meta-analysis of the efficacy of acupuncture and electroacupuncture against chemotherapy-induced peripheral neuropathy.
    Hwang MS; Lee HY; Choi TY; Lee JH; Ko YS; Jo DC; Do K; Lee JH; Park TY
    Medicine (Baltimore); 2020 Apr; 99(17):e19837. PubMed ID: 32332632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical study on concurrent use of electro-acupuncture or Chuna manual therapy with pregabalin for chemotherapy-induced peripheral neuropathy: safety and effectiveness (open-labeled, parallel, randomized controlled trial, assessor-blinded): A study protocol.
    Lee JH; Cho TJ; Park MG; Kim JH; Song SK; Park SY; Sunwoo YY; Lee I; Park TY
    Medicine (Baltimore); 2020 Jan; 99(3):e18830. PubMed ID: 32011497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
    Kurt S; Can G
    Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy.
    Song SY; Park JH; Lee JS; Kim JR; Sohn EH; Jung MS; Yoo HS
    Integr Cancer Ther; 2020; 19():1534735420925519. PubMed ID: 32493088
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluating Acupuncture for the Treatment of Chemotherapy-induced Peripheral Neuropathy: An Integrative Review.
    Kutcher AM; LeBaron VT
    West J Nurs Res; 2022 Feb; 44(2):169-179. PubMed ID: 33559535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
    Knoerl R; Weller E; Halpenny B; Berry D
    BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy.
    Li K; Giustini D; Seely D
    Curr Oncol; 2019 Apr; 26(2):e147-e154. PubMed ID: 31043820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy-Induced Peripheral Neuropathy Detection via a Smartphone App: Cross-sectional Pilot Study.
    Chen CS; Kim J; Garg N; Guntupalli H; Jagsi R; Griggs JJ; Sabel M; Dorsch MP; Callaghan BC; Hertz DL
    JMIR Mhealth Uhealth; 2021 Jul; 9(7):e27502. PubMed ID: 36260403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acupuncture and integrative oncology for taxane-induced peripheral neuropathy: a randomized multicentered study.
    Ben-Arye E; Gamus D; Samuels N; Schiff E; Hausner D; Gressel O; Attias S; Lavie O; David A; Shulman K; Agbarya A
    Int J Gynecol Cancer; 2023 May; 33(5):792-801. PubMed ID: 36600535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.
    Le-Rademacher J; Kanwar R; Seisler D; Pachman DR; Qin R; Abyzov A; Ruddy KJ; Banck MS; Lavoie Smith EM; Dorsey SG; Aaronson NK; Sloan J; Loprinzi CL; Beutler AS
    Support Care Cancer; 2017 Nov; 25(11):3537-3544. PubMed ID: 28634656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Cao A; Cartmel B; Li FY; Gottlieb LT; Harrigan M; Ligibel JA; Gogoi R; Schwartz PE; Esserman DA; Irwin ML; Ferrucci LM
    JAMA Netw Open; 2023 Aug; 6(8):e2326463. PubMed ID: 37526937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.
    Alberti P; Rossi E; Cornblath DR; Merkies IS; Postma TJ; Frigeni B; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Faber CG; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Valsecchi MG; Cavaletti G;
    Ann Oncol; 2014 Jan; 25(1):257-64. PubMed ID: 24256846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.